Capillary Blood Collection Devices Market Size & Growth Forecast 2027–2036, By Segments (Material, Product Type, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Capillary Blood Collection Devices Market size stood at USD 2.18 Billion in 2026 and is predicted to grow at 8.16% CAGR from 2027 to 2036, reaching USD 4.78 Billion by 2036. The industry revenue for 2027 is calculated at USD 2.33 Billion.

• Base Year Value (2026): USD 2.18 Billion
• CAGR (2027-2036): 8.16%
• Forecast Year Value (2036): USD 4.78 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Capillary Blood Collection Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America led in 2026 due to advanced healthcare infrastructure, established diagnostic networks, widespread testing, and growing demand for decentralized and home-based sampling.
  • Growth is supported by expanding healthcare access, rising diagnostic demand, infrastructure improvements, decentralized testing, and increasing need for convenient sampling across emerging economies.

• Segment Momentum:

  • Plastic accounted for 62.96% of the market in 2026 because it is lightweight, durable, breakage-resistant, and well suited for cost-effective disposable devices that support infection control and patient safety.
  • Lancing devices are the fastest-growing product type as ongoing improvements in safety, ergonomics, and ease of use support routine diagnostic testing and frequent blood monitoring in healthcare and home settings.

• Market Expansion Drivers:

  • Rising chronic disease prevalence driving frequent diagnostic testing requirements
  • Growing point-of-care testing adoption increasing demand for minimally invasive sampling
  • Expansion of home healthcare boosting self-collection diagnostic device utilization

• Leading Market Participants:

  Prominent companies in the capillary blood collection devices market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Terumo Corporation (Japan), Sarstedt AG & Co. KG (Germany), Cardinal Health, Inc. (United States), Greiner Bio-One International GmbH (Austria), Medtronic plc (Ireland), Danaher Corporation (United States)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 2.18 Billion
  • 2027 Estimated Market Size: USD 2.33 Billion
  • Projected Market Size: USD 4.78 Billion by 2036
  • Growth Forecasts: 8.16% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Plastic (Material) | Lancing Devices (Product Type) | Glucose Monitoring (Application) | Hospitals and Clinics (End-use)
  • Emerging Opportunity Segment: Plastic (Material) | Lancing Devices (Product Type) | Glucose Monitoring (Application) | Home Diagnosis (End-use)

Market Growth Drivers and Industry Trends

Rising chronic disease prevalence driving frequent diagnostic testing requirements

The increasing burden of long-term health conditions is creating sustained demand for regular monitoring and diagnostic procedures. Rising chronic disease prevalence is driving the capillary blood collection devices market growth as patients and healthcare providers seek convenient sampling solutions for repeated testing with minimal discomfort. These devices support routine assessments in areas where frequent blood analysis is required, including disease monitoring and preventive healthcare programs.

Growing point-of-care testing adoption increasing demand for minimally invasive sampling

Healthcare systems are expanding decentralized diagnostic approaches that enable faster testing closer to patients rather than relying solely on centralized laboratories. Growing point-of-care testing adoption will accelerate the capillary blood collection devices market growth by increasing the need for compact, easy-to-use sampling tools that support rapid diagnostic workflows. Minimally invasive collection methods improve patient comfort and simplify testing procedures across clinics, emergency settings, and other care environments.

Expansion of home healthcare boosting self-collection diagnostic device utilization

The shift toward patient-centered care models is encouraging greater use of diagnostic solutions outside traditional healthcare facilities. Expansion of home healthcare will strengthen the capillary blood collection devices market growth by increasing demand for self-collection devices that allow individuals to perform monitoring procedures conveniently at home. These solutions support remote healthcare programs by enabling easier sample collection while reducing the frequency of in-person visits for routine testing.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising chronic disease prevalence driving frequent diagnostic testing requirements	2%	High	North America, Europe	High	Near Term
Growing point-of-care testing adoption increasing demand for minimally invasive sampling	1.8%	High	North America, Asia Pacific	High	Near Term
Expansion of home healthcare boosting self-collection diagnostic device utilization	1.5%	Moderate	Europe, North America	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America led the capillary blood collection devices market in 2026, benefiting from advanced healthcare infrastructure, widespread diagnostic testing, and increasing demand for convenient blood sampling methods. The region's established laboratory and point-of-care testing networks support the adoption of devices designed to simplify sample collection while reducing the complexity associated with conventional blood-drawing procedures. Growing emphasis on decentralized diagnostics, home-based healthcare, and efficient testing workflows is also encouraging the use of capillary sampling technologies across healthcare settings.

Asia Pacific is expected to experience the fastest growth, supported by expanding healthcare access, rising demand for diagnostic testing, and improvements in medical infrastructure. Increasing healthcare expenditure and the development of decentralized and point-of-care diagnostic services are creating greater opportunities for capillary blood collection devices. The growing prevalence of chronic and infectious conditions is also strengthening the need for accessible testing, while healthcare modernization and wider availability of diagnostic facilities across emerging economies are supporting greater adoption of convenient blood collection technologies.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Material Segment Analysis: Plastic (Largest & Fastest-Growing Segment)

Holding the largest share of the capillary blood collection devices market, the plastic segment accounted for 62.96% in 2026 while also emerging as the fastest-growing material segment. Its widespread adoption is driven by its lightweight nature, durability, and resistance to breakage, making it highly suitable for routine blood collection procedures across hospitals, diagnostic laboratories, and point-of-care settings. Plastic materials also support cost-effective manufacturing and compatibility with disposable device designs, helping reduce contamination risks and improve patient safety. Continued emphasis on efficient sample collection and infection control practices is expected to sustain the segment’s strong market position and growth momentum.

Product Type Segment Analysis: Lancing Devices (Largest & Fastest-Growing Segment)

The lancing devices segment led the product type category in 2026 and also remained the fastest-growing segment. These devices play a critical role in obtaining capillary blood samples quickly and with minimal discomfort, making them indispensable for routine diagnostic testing. Continuous product improvements, including enhanced safety mechanisms, ergonomic designs, and greater ease of use, have encouraged broader adoption in both healthcare facilities and home care environments. Rising demand for frequent blood testing, particularly for chronic disease management, continues to reinforce the segment’s long-term expansion.

Application Segment Analysis: Glucose Monitoring (Largest &Fastest-Growing Segment)

The glucose monitoring segment dominated the capillary blood collection devices market in 2026 while also representing the fastest-growing application. Increasing prevalence of diabetes and the growing importance of regular blood glucose monitoring have significantly strengthened demand for reliable capillary blood collection solutions. Expanding adoption of home-based healthcare, coupled with improvements in portable diagnostic technologies, has further accelerated the use of these devices. Ongoing focus on early disease detection and continuous patient monitoring is expected to maintain the segment’s leading position.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Material	Plastic, Glass, Others	Plastic	Plastic
Product Type	Micro-container Tubes, Micro-hematocrit Tubes, Warming Devices, Lancing Devices, Others	Lancing Devices	Lancing Devices
Application	Glucose Monitoring, Hematocrit Testing, Cholesterol Testing, Coagulation Testing, Others	Glucose Monitoring	Glucose Monitoring
End-use	Hospitals and Clinics, Blood Banks, Diagnostic Centers, Home Diagnosis, Others	Hospitals and Clinics	Home Diagnosis

Competitive Landscape and Market Positioning

Top players in the capillary blood collection devices market:

1. Becton Dickinson and Company (United States)
2. Abbott Laboratories (United States)
3. F. Hoffmann-La Roche Ltd (Switzerland)
4. Siemens Healthineers AG (Germany)
5. Terumo Corporation (Japan)
6. Sarstedt AG & Co. KG (Germany)
7. Cardinal Health, Inc. (United States)
8. Greiner Bio-One International GmbH (Austria)
9. Medtronic plc (Ireland)
10. Danaher Corporation (United States)

Clinical workflow efficiency and patient-centered diagnostics are reshaping competitive dynamics in the capillary blood collection devices market, prompting manufacturers to prioritize ease of use, sample integrity, and compatibility with decentralized testing environments. Suppliers are expanding beyond conventional device offerings by incorporating ergonomic designs, safety-focused collection mechanisms, and solutions that support reliable specimen handling across hospitals, diagnostic laboratories, and home-based care settings. Competitive positioning increasingly depends on the ability to satisfy evolving clinical standards while addressing the growing demand for minimally invasive sampling, encouraging sustained investment in product refinement and application-specific innovation.

Industry Development/News

Company Name	Date	Key Development
RedDrop, Inc.	Feb-26	RedDrop, Inc. completed an IRB-approved, parent-administered home-use study of its RedDrop ONE capillary blood collection device involving 50 pediatric participants. The trial validated reliable sample collection, overnight shipment, and laboratory processing, proving the system's operational viability for decentralized pediatric diagnostics and remote patient monitoring workflows.
Becton, Dickinson and Company	Dec-23	Becton, Dickinson and Company secured FDA 510(k) clearances for its BD MiniDraw Collection System. The device enables low-volume capillary blood collection via fingersticks for lipid panels, selected chemistry tests, and hemoglobin/hematocrit testing, bringing lab-quality results to decentralized settings and expanding the company's diagnostic testing portfolio.
Becton, Dickinson and Company	Feb-20	Becton, Dickinson and Company entered into a long-term strategic partnership with Babson Diagnostics to deploy laboratory-quality, small-volume capillary blood collection services across retail pharmacies. The collaboration optimizes diagnostic testing distribution by shifting sample collection to convenient, customer-friendly retail healthcare environments.